Ld. Jayanthi et al., Differential regulation of mammalian brain-specific proline transporter bycalcium and calcium-dependent protein kinases, BR J PHARM, 129(3), 2000, pp. 465-470
1 This study examined the role of [Ca2+](I) and Ca2+-dependent kinases in t
he modulation of high-affinity, mammalian brain-specific L-proline transpor
ter (PROT).
2 beta-PMA (phorbol 12-myristate 13-acetate), an activator of protein kinas
e C (PKC), inhibits PRO uptake, and bisindolylmalemide I (BIM), a potent PK
C inhibitor, prevents beta-PMA inhibition. Down-regulation of PKC by chroni
c treatment with beta-PMA enhances PROT function indicating PROT regulation
by tonic activity of PKC.
3 Thapsigargin, which increases [Ca2+](I) levels by inhibiting Ca2+-ATPase,
inhibits PROT and exhibits additive inhibition when co-treated with beta-P
MA. KN-62, a Ca2+/calmodulin-dependent kinase II (CaMK II) inhibitor, but n
ot BIM (a PKC inhibitor) prevents the inhibition by thapsigargin. These dat
a suggest that PKC and CaMK II modulate PROT and that thapsigargin mediates
its effect via CaMK II.
4 Thapsigargin raises [Ca2+](I) and increases PRO-induced current on a seco
nd time scale, whereas the inhibitory effect of thapsigargin occurs only af
ter 10 min of treatment. These data suggest that Ca2+ differentially regula
te PROT: Ca2+ initially enhances PRO transport but eventually inhibits tran
sport function through CaMK II pathway.
5 Ca2+-induced stimulation exemplifies the acute regulation of a neurotrans
mitter transporter, which may play a critical role in the profile of neurot
ransmitters during synaptic transmission.